Is IZB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IZB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IZB (PLN43.2) is trading below our estimate of fair value (PLN112.98)
Significantly Below Fair Value: IZB is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IZB?
Key metric: As IZB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for IZB. This is calculated by dividing IZB's market cap by their current
earnings.
What is IZB's PE Ratio?
PE Ratio
3.9x
Earnings
zł13.90m
Market Cap
zł54.73m
IZB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: IZB is good value based on its Price-To-Earnings Ratio (3.9x) compared to the European Chemicals industry average (16.8x).
Price to Earnings Ratio vs Fair Ratio
What is IZB's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
IZB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
3.9x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IZB's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.